If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Michael J. Attubato, MD

NYU Langone Provider
  • Specialties: Interventional Cardiology, Cardiology
  • Treats: Adults
  • Languages: English, Spanish
  • Phone: 212-263-5656
View Locations

Conditions and Treatments

For Adults
Conditions
  • abnormal heart rhythms
  • acute coronary syndrome
  • angina
  • aortic valve disease
  • aortic valve insufficiency
  • aortic valve stenosis
  • aortoiliac occlusive disease
  • arteriosclerosis
  • carotid artery disease
  • carotid stenosis
  • chest pain
  • claudication
  • congestive heart failure
  • coronary artery disease
  • critical limb ischemia
  • heart attack
  • heart murmur
  • heart muscle disease
  • high blood pressure
  • inflammation of the heart valve
  • mitral valve regurgitation
  • mitral valve stenosis
  • peripheral vascular disease
  • renal artery stenosis
Treatments
  • angioplasty
  • arterial stent
  • cardiac catheterization
  • renal stent
  • stent placement
View All Conditions and Treatments
Learn more about conditions we treat at NYU Langone:
Aortic Valve Disease , Aortoiliac Occlusive Disease , Carotid Artery Disease , Coronary Artery Disease , High Blood Pressure , Renal Artery Stenosis

Positions
Board Certifications
  • American Board of Internal Medicine (Cardiovascular Disease), 1987
  • American Board of Internal Medicine - Internal Medicine, 1984
Education and Training
  • Fellowship, NYU Medical Center, Cardiology, 1987
  • Residency, NYU Medical Center, Internal Medicine, 1985
  • MD from New York University, 1981

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Michael J. Attubato, MD does not accept insurance.

Locations and Appointments

NYU Langone Cardiac Catheterization Associates

550 First Avenue, 14th Floor, New York, NY 10016

View Map
Phone

212-263-5656

Fax

212-263-8534

Interests

antithrombin and antiplatelet regimens for coronary intervention, TAVR, endovascular treatment modalities for peripheral arterial disease, coronary artery disease, diabetes, transcatheter aortic valve replacement, intravascular ultrasound

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • The Heart Attack Research Program (HARP) is a multi-discipline and mutli-center study that incorporates clinical and basic science and population health to investigate mechanisms of disease in women with Myocardial Infarction with Non-Obstructive Coronary

    Learn More

  • The primary objective of the PROTECT IV Trial is to demonstrate the superiority of percutaneous coronary intervention (PCI) performed with Impella mechanical circulatory support (MCS; Impella CP Impella CP with SmartAssist or Impella 2.5 devices) com

    Learn More

  • The primary objective of this trial is to test whether FFRangio -guided treatment is noninferior to conventional pressure wire-guided treatment in patients with coronary artery disease being evaluated for percutaneous coronary intervention (PCI) with resp

    Learn More
View All Research Studies (3)

Read All Publications (75)

Related News

Don’t Delay Care: How Charley Survived a Heart Attack
Read Story